For tirzepatide, fridge storage guidelines apply similarly
Liraglutide, long-acting GLP-1 agonist, has also been shown to induce significant weight loss and reduce SBP in a group of Asian patients [134]
While randomized prevention trials are still needed, the consistency and biological coherence of current data support cautious optimism
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
Pay particular attention to IGF-1 levels (which should rise with Tesamorelin but stay within a healthy reference range), fasting glucose and insulin (to monitor for any GH-related insulin resistance), liver enzymes (both compounds have liver-protective effects, but monitoring confirms this), and lipid panels (you should see improvements in triglycerides and LDL)
Your doctor (not you directly) can call Lilly at 1-800-545-5979 (1-800-Lilly-Rx)